Healthcare News 17 November 2025

AbbVie (ABBV) Stock Outlook Before the December 1, 2025 Open: Skyrizi’s Canada Win, Medicare Cuts and Fresh Analyst Targets

AbbVie Inc. (NYSE: ABBV) heads into Monday’s December 1, 2025 open sitting near the middle of its recent trading range, with a lot of fresh information for investors to digest from November 28–30. As of the latest close on November

30 November 2025

UnitedHealth Group (UNH) Stock Outlook Before December 1, 2025: Can Bulls Look Past DOJ Risk and Medicare Pressures?

As Wall Street gets ready for trading on Monday, December 1, 2025, UnitedHealth Group Incorporated (NYSE: UNH) heads into December as one of the most closely watched – and most controversial – names in the Dow. After Friday’s shortened session

30 November 2025

Financial News · Healthcare · Investment Strategies · Market Outlook · NYSE:UNH · Stock Analysis

Mercy Ships’ Cargo Day 2025 Targets Record $2.5m as Cisco and Presidio Power Floating Hospitals

On 27 November 2025, Mercy Ships’ flagship fundraising event, Cargo Day, is on track for its biggest haul yet – and this year’s push is tightly linked to a major digital upgrade of the charity’s floating hospital fleet, powered by

27 November 2025

Charity · Fundraising · Healthcare · NASDAQ:CSCO · NASDAQ:PSDO · Shipping · Technology

Novo Nordisk (NVO) Stock Rebounds as Wegovy Upgrade and Medicare Deal Ease Pricing Fears – 26 November 2025

Novo Nordisk A/S stock is staging a sharp rebound today, 26 November 2025, as investors digest a trio of major developments: an FDA filing for a higher-dose version of its blockbuster obesity drug Wegovy, clarity on steep—but largely expected—Medicare price

26 November 2025

Financial Analysis · Healthcare · Investment News · Pharmaceuticals · Stock Market

UnitedHealth Group (UNH) Stock Today, November 26, 2025: Price Action, Medicare Shockwaves and What Investors Are Watching

UnitedHealth Group Incorporated (NYSE: UNH) shares traded higher on Wednesday, November 26, 2025, as Wall Street digested fresh headlines on Medicare commissions, tense hospital contract talks and new institutional trading disclosures. In late trading, UNH was changing hands around $330–331,

26 November 2025

Financial News · Healthcare · Investing · Medicare · NYSE:UNH · Stock Market

ASX Today: Australian Share Market Rebounds Over 1% as Tech, Healthcare and Industrials Lead – 24 November 2025

Sydney – Monday, 24 November 2025 — The Australian stock market kicked off the week with a strong relief rally, snapping a painful run of November losses as investors piled back into technology, healthcare and industrial names on renewed hopes of

25 November 2025

Australia · Finance · Healthcare · Stock Market · Technology

Oscar Health (OSCR) Stock Soars on Obamacare Subsidy Hopes as AI-Powered Virtual Care Rewrites Its Growth Story

Oscar Health Inc. (NYSE: OSCR) is back in the spotlight on Monday, November 24, 2025, as its stock surges on reports of a potential extension of Obamacare subsidies — just days after fresh analysis highlighted how AI-driven virtual care, new

24 November 2025

Artificial Intelligence · Healthcare · Insurance · NYSE:OSCR · Stock Market · Technology

Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle Stock Today, November 20, 2025: ORCL Slides as AI Debt Jitters Offset Health-Care Wins

Oracle Corporation (NYSE: ORCL) shares were under pressure on Thursday, November 20, 2025, as growing concerns over the company’s AI‑driven debt load and rising credit risk overshadowed a string of positive announcements in its healthcare and defense businesses. By late

20 November 2025

Artificial Intelligence · Financial News · Healthcare · Oracle · Stock Market

Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories (NYSE: ABT) shook the healthcare and medtech markets today, November 20, 2025, by announcing a definitive agreement to acquire cancer diagnostics specialist Exact Sciences Corporation (NASDAQ: EXAS) in an all‑cash transaction valuing the target at about $21 billion

20 November 2025

Cancer Research · Healthcare · Medical Technology · Mergers & Acquisitions · NASDAQ:EXAS · NYSE:ABT · Stock Market News

Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott has agreed to acquire cancer diagnostics specialist Exact Sciences in a cash deal valued at about $21 billion in equity, or roughly $23 billion including debt, in one of the biggest healthcare transactions of 2025 and Abbott’s largest deal

20 November 2025

Business News · Cancer Research · Healthcare · Medical Technology · Mergers & Acquisitions · NASDAQ:EXAS · NYSE:ABT

Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott Nears Takeover of Exact Sciences, Sending Cancer Test Maker’s Stock Soaring on November 19, 2025

Abbott Laboratories is in advanced talks to acquire cancer diagnostics specialist Exact Sciences, in what could be the healthcare giant’s largest deal in nearly a decade and a major shake-up for the global cancer testing market. Bloomberg+1 Abbott in Talks

19 November 2025

Cancer Research · Healthcare · Medical Technology · Mergers & Acquisitions · Stock Market

LifeMD (LFMD) Slashes Wegovy and Ozempic Cash-Pay Price to $199 as Q3 2025 Earnings and GLP‑1 Price War Heat Up

LifeMD (NASDAQ: LFMD) announced the lowest nationwide cash-pay pricing for Wegovy and Ozempic at $199 per month for new patients, just hours before its rescheduled Q3 2025 earnings release. Here’s what it means for patients, investors, and the GLP‑1 weight-loss

17 November 2025

Business News · Drug Pricing · Healthcare · Pharma Industry · Stock Market

Healthcare News 17 November 2025 - 30 November 2025